Lupin 2024

The Drug Price Transparency Act

PCMA issues statement on prescription drug rebate legislation

PCMA issues statement on prescription drug rebate legislation

WASHINGTON — Pharmaceutical Care Management president and chief executive officer J.C. Scott issued the following statement on newly introduced legislation by Senator Mike Braun (R, Ind.), “The Drug Price Transparency Act:” “We stand ready to work with Senator Braun and other policymakers who share the goal of reducing high drug costs. Pharmacy benefit managers (PBMs) are the

PP_1170x120_10-25-21